Literature DB >> 21934280

De novo interstitial triplication of MECP2 in a girl with neurodevelopmental disorder and random X chromosome inactivation.

S Mayo1, S Monfort, M Roselló, C Orellana, S Oltra, J Armstrong, V Català, F Martínez.   

Abstract

Loss-of-function mutations of the MECP2 gene are the cause of most cases of Rett syndrome in females, a progressive neurodevelopmental disorder characterized by severe mental retardation, global regression, hand stereotypies, and microcephaly. On the other hand, gain of dosage of this gene causes the MECP2 duplication syndrome in males characterized by severe mental retardation, absence of speech development, infantile hypotonia, progressive spasticity, recurrent infections, and facial dysmorphism. Female carriers of a heterozygous duplication show a skewed X-inactivation pattern which is the most probable cause of the lack of clinical symptoms. In this paper, we describe a girl with a complex de novo copy number gain at Xq28 and non-skewed X-inactivation pattern that causes mental retardation and motor and language delay. This rearrangement implies triplication of the MECP2 and IRAK1 genes, but it does not span other proximal genes located in the common minimal region of patients affected by the MECP2 duplication syndrome. We conclude that the triplication leads to a severe phenotype due to random X-inactivation, while the preferential X chromosome inactivation in healthy carriers may be caused by a negative selection effect of the duplication on some proximal genes like ARD1A or HCFC1.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21934280     DOI: 10.1159/000330917

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  10 in total

1.  De novo MECP2 duplications in two females with intellectual disability and unfavorable complete skewed X-inactivation.

Authors:  Nathalie Fieremans; Marijke Bauters; Stefanie Belet; Jelle Verbeeck; Anna C Jansen; Sara Seneca; Filip Roelens; Elfride De Baere; Peter Marynen; Guy Froyen
Journal:  Hum Genet       Date:  2014-07-19       Impact factor: 4.132

2.  Xq28 duplications including MECP2 in five females: Expanding the phenotype to severe mental retardation.

Authors:  E K Bijlsma; A Collins; F T Papa; M I Tejada; P Wheeler; E A J Peeters; A C J Gijsbers; J M van de Kamp; M Kriek; M Losekoot; A J Broekma; J A Crolla; M Pollazzon; M Mucciolo; E Katzaki; V Disciglio; M I Ferreri; A Marozza; M A Mencarelli; C Castagnini; L Dosa; F Ariani; F Mari; R Canitano; G Hayek; M P Botella; B Gener; M Mínguez; A Renieri; C A L Ruivenkamp
Journal:  Eur J Med Genet       Date:  2012-03-29       Impact factor: 2.708

3.  In Pursuit of New Imprinting Syndromes by Epimutation Screening in Idiopathic Neurodevelopmental Disorder Patients.

Authors:  Sonia Mayo; Sandra Monfort; Mónica Roselló; Silvestre Oltra; Carmen Orellana; Francisco Martínez
Journal:  Biomed Res Int       Date:  2015-05-27       Impact factor: 3.411

Review 4.  Clinical impacts of genomic copy number gains at Xq28.

Authors:  Toshiyuki Yamamoto; Keiko Shimojima; Shino Shimada; Kenji Yokochi; Shinsaku Yoshitomi; Keiko Yanagihara; Katsumi Imai; Nobuhiko Okamoto
Journal:  Hum Genome Var       Date:  2014-07-24

5.  The presence of two rare genomic syndromes, 1q21 deletion and Xq28 duplication, segregating independently in a family with intellectual disability.

Authors:  Kyungsoo Ha; Yiping Shen; Tyler Graves; Cheol-Hee Kim; Hyung-Goo Kim
Journal:  Mol Cytogenet       Date:  2016-09-29       Impact factor: 2.009

6.  MECP2 Duplications in Symptomatic Females: Report on 3 Patients Showing the Broad Phenotypic Spectrum.

Authors:  Victoria San Antonio-Arce; María Fenollar-Cortés; Raluca Oancea Ionescu; Teresa DeSantos-Moreno; Jesús Gallego-Merlo; Francisco José Illana Cámara; María Carmen Cotarelo Pérez
Journal:  Child Neurol Open       Date:  2016-04-04

7.  A sibship with duplication of Xq28 inherited from the mother; genomic characterization and clinical outcomes.

Authors:  Dong Keon Yon; Ji Eun Park; Seung Jun Kim; Sung Han Shim; Kyu Young Chae
Journal:  BMC Med Genet       Date:  2017-03-17       Impact factor: 2.103

8.  Infectious and immunologic phenotype of MECP2 duplication syndrome.

Authors:  Michael Bauer; Uwe Kölsch; Renate Krüger; Nadine Unterwalder; Karin Hameister; Fabian Marc Kaiser; Aglaia Vignoli; Rainer Rossi; Maria Pilar Botella; Magdalena Budisteanu; Monica Rosello; Carmen Orellana; Maria Isabel Tejada; Sorina Mihaela Papuc; Oliver Patat; Sophie Julia; Renaud Touraine; Thusari Gomes; Kirsten Wenner; Xiu Xu; Alexandra Afenjar; Annick Toutain; Nicole Philip; Aleksandra Jezela-Stanek; Ludwig Gortner; Francisco Martinez; Bernard Echenne; Volker Wahn; Christian Meisel; Dagmar Wieczorek; Salima El-Chehadeh; Hilde Van Esch; Horst von Bernuth
Journal:  J Clin Immunol       Date:  2015-02-27       Impact factor: 8.317

Review 9.  A brief history of MECP2 duplication syndrome: 20-years of clinical understanding.

Authors:  Daniel Ta; Jenny Downs; Gareth Baynam; Andrew Wilson; Peter Richmond; Helen Leonard
Journal:  Orphanet J Rare Dis       Date:  2022-03-21       Impact factor: 4.123

10.  A partial MECP2 duplication in a mildly affected adult male: a putative role for the 3' untranslated region in the MECP2 duplication phenotype.

Authors:  Neil A Hanchard; Claudia M B Carvalho; Patricia Bader; Aaron Thome; Lisa Omo-Griffith; Daniela del Gaudio; Davut Pehlivan; Ping Fang; Christian P Schaaf; Melissa B Ramocki; James R Lupski; Sau Wai Cheung
Journal:  BMC Med Genet       Date:  2012-08-10       Impact factor: 2.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.